Master Alliance Provisions Guide (MAPGuide)

NIH Model License Agreement for Use by Non-Profit

  • IP ownership & licensing | Use of background IP

By law and policy, NIH favors non-exclusive licenses.  Licenses to platform technologies, including in the field of diagnostics, will be available on a nonexclusive basis or in some cases under an exclusive license with very narrow product specific limitations.  Consistent with applicable laws, regulations and policies, exclusive licenses will be considered for potential drug (small molecular entities and biologics) and vaccine components and will be limited to defined indications and territories.  Nonexclusive licenses will be available for technologies to the extent defined indications and territories are not already licensed exclusively or subject to an exclusive license option under a CRADA.